Financial PerformanceDespite a strong quarter, expectations were high, and the stock indicated a decline due to shorter-term profit taking.
Market CompetitionSoftness in the base glaucoma business has been noted, attributed to LCD headwinds for MIGS and increased competition in overseas markets.
Product PerformanceMixed survey results for MIGS show a decline in expected iStent W volumes by 6%, contributing to a net share loss for GKOS's iStent franchise.